The Role of Platelet Surface α2β1 Integrin Expression as a Risk Factor in Thrombotic and/or Bleeding Complications
Clinical trial NCT00603148 · COMPLETED
Trial details
- NCT number
- NCT00603148
- Sponsor
- Vanderbilt University
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2006-09-01
- Primary completion
- 2010-02-01
- Enrollment
- 475
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.